The Smt. Kamal Satbir Award was instituted in 1987 by Commodore Satbir, AVSM, I.N. (Retd.) in memory of wife Smt. Kamal for significant research contribution by young scientists in biomedical sciences. This prize is awarded for the best published research work in the field of non-tubrculous Chest Diseases, especially Respiratory Allergy and Chronic Obstructive Lung Diseases pertaining to mechanism and causation of the diseases, their prevention and / or management. The award for the year 2014 is being presented to Dr. Navneet Singh, Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh for the research work on 'Clinico - epidemiological profile of lung cancer in north India and its association with quantified tobacco smoking'. Dr. Singh's work on lung cancer focuses on molecular biology, epidemiology, symptom assessment using simple scoring systems and management in resource constrained settings. His work demonstrated geographical diversity in the epidemiological profile of lung cancer within India and also that there are several differences from developed countries. Quantified tobacco smoke exposure has a significant and important association with the clinical profile of lung cancer patients at diagnosis.

The Shakuntala Amir Chand Prize was instituted in 1953 by late Major General Amir Chand for significant research contribution by young scientists in biomedical sciences. This prize is awarded for the best published research work on any subject in the field of biomedical science including clinical research. The award for the year 2014 is being presented to Dr. Nooruddin Khan, Lab of Immunology and Infectious Diseases, Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad for the research work on 'Molecular mechanism of vaccine induced protective immunity'. The findings of Dr. Khan's Group reveal that yellow fever vaccine (YF17D) activates GCN2 to program dendritic cells to initiate autophagy and enhanced antigen-presentation to T cells. These findings have potential bearing for the design and development of novel vaccine formulation against emerging infectious diseases.

The JALMA Trust Fund Oration Award for Leprosy and Other Mycobacterial Diseases was instituted by National JALMA institute for Leprosy & Other Mycobacterial Diseases, Agra for scientists who have contributed significantly in the field of leprosy and other mycobacterial diseases. The prize for year 2014 is being presented to Dr. Beenu Joshi, ICMR-National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra for the research work on 'Unravelling the mechanism of T cell unresponsiveness in leprosy and TB, search for new antigens for the diagnosis and vaccine candidate for TB'. Research work of Dr. Beenu Joshi revealed mechanism of T cell activation leading to unresponsiveness and role of calcium signalling and MAP kinase pathways in the survival of bacteria and disease pathogenesis in TB and leprosy. For TB diagnosis, Ag85c antigen was noted to have diagnostic potential for paediatric TB. Certain proteins in Mycobacterium tuberculosis isolates were shown with increased intensity which could prove important for TB diagnosis or as vaccine candidate(s).

The ICMR Prize for Biomedical Research for Scientists Belonging to Underprivileged Communities was instituted by ICMR in 1983 for scientists belonging to Scheduled Caste/Scheduled Tribe/Backward Classes and who have contributed significantly to the field of biomedical sciences. This prize is offered to a research scientist for his/her outstanding and sustained contributions in any field of biomedical sciences. The Award for the year 2014 is being presented to Dr. Kumpati Premkumar, Department of Biomedical Science, School of Basic Medical Sciences, Bharathidasan University, Tiruchirappalli for the research work on 'Doxorubicin conjugated gold nanorods: A sustained drug delivery carrier for improved anticancer therapy'. His research focuses on understanding the genetic basis of cancer and developing nanobased strategies for combating cancer, overcoming the drawbacks of classical chemotherapy. Dr. Premkumar's group developed size tunable doxorubicin conjugated gold nanorods as nanotheranostics, with better cellular internalization, limited cardiotoxicity and complete cancer regression when subjected to laser mediated hyperthermia.